Ranking Alexa Global: # 323,298,Alexa Ranking in United States is # 164,373
Server:Apache...
The main IP address: 54.246.104.24,Your server Ireland,Dublin ISP:Amazon Technologies Inc. TLD:com CountryCode:IE
The description :thought leadership and innovation for the pharmaceutical industry...
This report updates in 15-Jun-2018
Created Date: | 2000-01-18 |
Changed Date: | 2017-01-19 |
Expires Date: | 2019-01-18 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host social.eyeforpharma.com. Currently, hosted in Ireland and its service provider is Amazon Technologies Inc. .
Latitude: | 53.343990325928 |
Longitude: | -6.2671899795532 |
Country: | Ireland (IE) |
City: | Dublin |
Region: | Dublin City |
ISP: | Amazon Technologies Inc. |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.
Content-Length: | 87662 |
Via: | 1.1 varnish |
X-Content-Type-Options: | nosniff, nosniff |
Content-Language: | en |
X-Varnish-Cache: | HIT |
Accept-Ranges: | bytes |
Expires: | Sun, 19 Nov 1978 05:00:00 GMT |
Vary: | Cookie |
X-Varnish: | 1578755397 1578735605 |
Server: | Apache |
Last-Modified: | Fri, 15 Jun 2018 10:54:52 GMT |
Connection: | keep-alive |
Etag: | "1529060092-0" |
Link: | |
Cache-Control: | public, max-age=21600 |
Date: | Fri, 15 Jun 2018 11:37:14 GMT |
X-Frame-Options: | SAMEORIGIN |
Content-Type: | text/html; charset=utf-8 |
Age: | 2540 |
cname: | multibalancer-692535398.eu-west-1.elb.amazonaws.com. |
ipv4: | IP:54.246.104.24 ASN:16509 OWNER:AMAZON-02 - Amazon.com, Inc., US Country:US IP:54.217.208.139 ASN:16509 OWNER:AMAZON-02 - Amazon.com, Inc., US Country:US |
-- login username or e-mail * password * forgotten password? subscribe | forgot your password? close log in window on demand | newsletter | log in thought leadership and innovation for the pharmaceutical industry search this site home topics commercial access and evidence clinical patients and medical research reports custom white papers conference slides, videos, audio webinars reports events past event content on demand what is on demand? subscribe free trial about/contact contact us management team menu -- patient access the naked truth about outcomes-based pricing hype around outcomes-based contracts has been doing the rounds for some time now, but is pharma delivering the goods? column where next for digital support programs? ‘beyond the pill’ patient support services are set to become a key differentiator for pharma companies, but a new approach is needed patients and medical the power of empathy in a bid to better understand and engage patients, pharma companies are becoming as compassionate as they are scientific. latest patients and medical the power of empathy adam chapman , ( jun 12, 2018 ) in a bid to better understand and engage patients, pharma companies are becoming as compassionate as they are scientific. commercial artificial intelligence: the counter-argument adam chapman , ( jun 7, 2018 ) ai is being touted as the doctor’s new lifeline — we put this proposition to a skeptical doctor. commercial sizing up pharma’s tech maturity andrew stone , ( jun 1, 2018 ) amateurs or aficionados? we get an expert appraisal of the industry’s tech proficiency access and evidence the naked truth about outcomes-based pricing ross davies , ( may 22, 2018 ) hype around outcomes-based contracts has been doing the rounds for some time now, but is pharma delivering the goods? patients and medical pharma, stop flummoxing patients danielle barron , ( may 15, 2018 ) efforts to empower patients are undermined by bamboozling medical information. is there a straight-forward solution? more content opinion where next for digital support programs? jim o'donoghue , ( jun 15, 2018 ) ‘beyond the pill’ patient support services are set to become a key differentiator for pharma companies, but a new approach is needed good intentions, bad habits: reforming mental healthcare in latam marc yates , ( apr 9, 2018 ) mental health reforms across latin america are transforming attitudes and services but what can pharma do to help speed up the transition? helping patients learn healthy habits steve peretz an... , ( apr 5, 2018 ) building for lasting behavior change with a patient-centric, research-driven approach to health innovation rare diseases: a new purpose preeti patel an... , ( mar 31, 2018 ) drug repurposing could help drive orphan drug access if pharma can accept the risks why pharma needs to understand population health rita numerof , ( feb 26, 2018 ) in the new health ecosystem, pharma needs to know a lot more about population health more columns commercial artificial intelligence: the counter-argument adam chapman , ( jun 7, 2018 ) ai is being touted as the doctor’s new lifeline — we put this proposition to a skeptical doctor. sizing up pharma’s tech maturity andrew stone , ( jun 1, 2018 ) amateurs or aficionados? we get an expert appraisal of the industry’s tech proficiency leadership in japan ross davies , ( may 11, 2018 ) in the face of new drug pricing reforms, the need to nurture strong leadership is imperative, but not without its challenges. how well do you know your hcp? adam chapman , ( may 3, 2018 ) machine learning is a boon for customer engagement. how can pharma best use it? achieving success in emerging markets andrew lane , ( apr 21, 2018 ) patients and doctors in emerging markets want more than just high-quality medicines, says andrew lane from abbott more commercial access and evidence the naked truth about outcomes-based pricing ross davies , ( may 22, 2018 ) hype around outcomes-based contracts has been doing the rounds for some time now, but is pharma delivering the goods? how to attract investors ross davies , ( may 4, 2018 ) the precarious climate in the us might have spooked some pharma investors – but others are looking to targeted therapies to get more bang for their buck. japan’s perilous new pricing policy ross davies , ( apr 13, 2018 ) the introduction of a new drug pricing reform in japan has pharma up in arms. are their fears justified? digital health tools are no fad adam chapman , ( mar 14, 2018 ) data generating devices may seem gimmicky, but they are poised to transform healthcare overcoming the access hurdle adam chapman , ( mar 6, 2018 ) if pharma is to keep whizzing ahead, it needs to rethink its approach to market access more market access patients and medical the power of empathy adam chapman , ( jun 12, 2018 ) in a bid to better understand and engage patients, pharma companies are becoming as compassionate as they are scientific. pharma, stop flummoxing patients danielle barron , ( may 15, 2018 ) efforts to empower patients are undermined by bamboozling medical information. is there a straight-forward solution? could behavioral science crack non-adherence? katie osborne , ( apr 19, 2018 ) the industry is looking to the field of psychology to answer one of its most protracted problems trio takes home team prize adam chapman , ( apr 11, 2018 ) allergan, sonarmd and illinois gastroenterology group’s (igg) joint efforts to improve the lives of ibs patients earns them the most valuable collaboration award an ode to efficiency adam chapman , ( apr 11, 2018 ) a multi-pronged approach to improving a common hospital procedure wins distinguished award more patients and medical latest videos act like sars and go viral with patient centricity ceo of leo pharma on how they are driving collaborations peter guenter, evp, sanofi on his ambition to cure diabetes ceos of sandoz and leo discuss pharma’s reputation - admit mistakes and ‘own’ healthcare problems sandoz, ceo: pharma and healthcare are misaligned when it comes to health outcomes most popular the naked truth about outcomes-based pricing sizing up pharma’s tech maturity artificial intelligence: the counter-argument the future of real-world evidence: optimising outcomes maintain your external authenticity as your internal importance increases in-depth analysis trends in market access trends in medical affairs trends in real-world evidence patient centricity works trends in sales excellence trends in marketing upcoming events october 2018 sydney 2018 oct 10, 2018 - oct 11, 2018 sydney patient summit europe 2018 oct 16, 2018 - oct 17, 2018 london marketing and customer innovation europe 2018 oct 16, 2018 - oct 17, 2018 london patient summit usa 2018 oct 23, 2018 - oct 24, 2018 philadelphia november 2018 data, evidence, access usa 2018 nov 7, 2018 - nov 8, 2018 philadelphia marketing and customer innovation usa 2018 nov 14, 2018 - nov 15, 2018 philadelphia march 2019 awards judging day 2019 - europe mar 11, 2019 - mar 11, 2019 barcelona barcelona 2019 mar 12, 2019 - mar 14, 2019 barcelona medical affairs europe 2019 mar 12, 2019 - mar 14, 2019 barcelona latest reports our entire range of industry leading reports are listed below. each is either available in full to our premium subscribers or available for purchase. standard subscribers can view extracts of each report for free. click the links for more details. the role of the sales representative in a multichannel world 2015 published: december 2015 advancing multichannel customer engagement in pharma pharma marketing data infrastructure 2015 published: july 2015 handle the data your marketing needs. customer experience management 2015 put the customer at the centre of your strategy, organization and capabilities. value added services 2015 3 tailored roadmap's to solutions in healthcare beyond the pill. key customer engagement 2015 published: september 2015 a guide of best practices to developing strategy, organization, human resources
http://social.eyeforpharma.com/
http://social.eyeforpharma.com/reports
http://social.eyeforpharma.com/events
http://social.eyeforpharma.com/evidence/medical-scientific-liaisons-sales-reps-disguise
http://social.eyeforpharma.com/uncategorised/seven-worst-mistakes-pharma-launch-and-secrets-avoid-them
http://social.eyeforpharma.com/market-access/real-world-evidence-maximize-benefits-healthcare
http://social.eyeforpharma.com/evidence/pfizer-integrated-health-lessons-rolling-out-service
http://social.eyeforpharma.com/column/ladder-adoption-different-approach
http://social.eyeforpharma.com/market-access/making-tenders-work-globally-pfizer-approach
http://social.eyeforpharma.com/column/future-pharma-sales-part-i
http://social.eyeforpharma.com/column/role-salesperson-how-person-can-make-or-break-sale
http://social.eyeforpharma.com/commercial/5-keys-successful-sales-force-integration-post-merger
http://social.eyeforpharma.com/column/what-you-need-know-about-late-stage-clinical-trials
http://social.eyeforpharma.com/market-access/audio-slides/hta-pricing-and-reimbursement-france
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain Name: EYEFORPHARMA.COM
Registrar URL: http://www.godaddy.com
Registrant Name: Fatou Bah
Registrant Organization: FC Business Intelligence Ltd
Name Server: NS-1590.AWSDNS-06.CO.UK
Name Server: NS-439.AWSDNS-54.COM
Name Server: NS-1361.AWSDNS-42.ORG
Name Server: NS-650.AWSDNS-17.NET
DNSSEC: unsigned
For complete domain details go to:
http://who.godaddy.com/whoischeck.aspx?domain=EYEFORPHARMA.COM
The data contained in GoDaddy.com, LLC's WhoIs database,
while believed by the company to be reliable, is provided "as is"
with no guarantee or warranties regarding its accuracy. This
information is provided for the sole purpose of assisting you
in obtaining information about domain name registration records.
Any use of this data for any other purpose is expressly forbidden without the prior written
permission of GoDaddy.com, LLC. By submitting an inquiry,
you agree to these terms of usage and limitations of warranty. In particular,
you agree not to use this data to allow, enable, or otherwise make possible,
dissemination or collection of this data, in part or in its entirety, for any
purpose, such as the transmission of unsolicited advertising and
and solicitations of any kind, including spam. You further agree
not to use this data to enable high volume, automated or robotic electronic
processes designed to collect or compile this data for any purpose,
including mining this data for your own personal or commercial purposes.
Please note: the registrant of the domain name is specified
in the "registrant" section. In most cases, GoDaddy.com, LLC
is not the registrant of domain names listed in this database.
REGISTRAR GODADDY.COM, LLC
REFERRER http://www.godaddy.com
SERVERS
SERVER com.whois-servers.net
ARGS domain =eyeforpharma.com
PORT 43
SERVER whois.godaddy.com
ARGS eyeforpharma.com
PORT 43
TYPE domain
DOMAIN
NAME eyeforpharma.com
NSERVER
NS-1361.AWSDNS-42.ORG 205.251.197.81
NS-1590.AWSDNS-06.CO.UK 205.251.198.54
NS-439.AWSDNS-54.COM 205.251.193.183
NS-650.AWSDNS-17.NET 205.251.194.138
STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientRenewProhibited https://icann.org/epp#clientRenewProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
CHANGED 2017-01-19
CREATED 2000-01-18
EXPIRES 2019-01-18
OWNER
ADMIN
TECH
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .